At least 55 lawsuits accusing drugmakers Novo Nordisk and Eli Lilly of failing to warn people about harsh side effects associated with their blockbuster diabetes and weight loss drugs Ozempic and Mounjaro will be centralized in a Pennsylvania federal court, according to an order issued on Friday.